KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,463 | +38.7% | 6,652 | +129.5% | 0.00% | +50.0% |
| Q2 2023 | $66,648 | +128069.2% | 2,899 | +65.4% | 0.00% | 0.0% |
| Q1 2023 | $52 | -61.5% | 1,753 | -67.5% | 0.00% | -66.7% |
| Q4 2022 | $135 | -100.0% | 5,399 | -71.0% | 0.01% | -14.3% |
| Q3 2022 | $405,000 | +78.4% | 18,622 | +61.5% | 0.01% | +40.0% |
| Q2 2022 | $227,000 | +69.4% | 11,529 | +264.2% | 0.01% | +400.0% |
| Q1 2022 | $134,000 | -54.3% | 3,166 | -31.4% | 0.00% | -80.0% |
| Q4 2021 | $293,000 | +34.4% | 4,616 | +24.6% | 0.01% | -16.7% |
| Q3 2021 | $218,000 | +162.7% | 3,706 | +115.5% | 0.01% | +200.0% |
| Q2 2021 | $83,000 | +43.1% | 1,720 | +15.9% | 0.00% | +100.0% |
| Q1 2021 | $58,000 | +23.4% | 1,484 | +97.9% | 0.00% | 0.0% |
| Q4 2020 | $47,000 | +51.6% | 750 | -22.7% | 0.00% | – |
| Q3 2020 | $31,000 | – | 970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |